Skip to main content
Top
Published in: Sleep and Breathing 3/2020

01-09-2020 | Restless Legs Syndrome | Sleep Breathing Physiology and Disorders • Original Article

Autonomic dysfunction in restless legs syndrome

Authors: Yuksel Erdal, Ozlem Akdogan, Mecbure Nalbantoglu, Gokce Kavasoglu, Ufuk Emre

Published in: Sleep and Breathing | Issue 3/2020

Login to get access

Abstract

Objective

Autonomic dysfunction in patients with RLS has been described in some domains; however, detailed studies on this subject are limited and report conflicting results. In this study, we aimed to evaluate autonomic functions electrophysiologically and clinically in patients with restless legs syndrome (RLS).

Methods

Fifty-two adult patients with RLS and 40 healthy controls were enrolled in this prospective study. Electrophysiological tests of sympathetic skin response (SSR) and RR interval variability (RRIV) analysis were performed, and the SCOPA-AUT questionnaire was applied to evaluate autonomic functions.

Results

There was no significant difference in terms of SSR results between patients and controls (p > 0.05). However, there were significant differences between the patient and control groups in terms of RRIV analyses at rest, deep breathing, and valsalva, and also valsalva ratio (p = 0.037, p = 0.049, p = 0.017, p = 0.020). The mean SCOPA-AUT total score was higher in the RLS group compared with the control group (20.7 ± 10 vs 14.2 ± 8; p = 0.003). Significant differences were found regarding gastrointestinal, urinary, and cardiovascular domains (p = 0.01, p = 0.007, p = 0.049); on the other hand, pupillomotor, thermoregulatory, and sexual function did not significantly differ (p > 0.05).

Conclusion

Autonomic functions should be questioned in detail as well as motor and sensory symptoms of RLS, and care should be taken especially on cardiac dysfunction.
Literature
1.
go back to reference Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 15:860–873CrossRef Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 15:860–873CrossRef
2.
go back to reference Wijemanne S, Ondo W (2017) Restless legs syndrome: clinical features, diagnosis and a practical approach to management. Pract Neurol 17:444–452CrossRef Wijemanne S, Ondo W (2017) Restless legs syndrome: clinical features, diagnosis and a practical approach to management. Pract Neurol 17:444–452CrossRef
3.
go back to reference Ohayon MM, O'Hara R, Vitiello MV (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16:283–295CrossRef Ohayon MM, O'Hara R, Vitiello MV (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16:283–295CrossRef
4.
go back to reference Trenkwalder C, Hogl B, Winkelmann J (2009) Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 256:539–553CrossRef Trenkwalder C, Hogl B, Winkelmann J (2009) Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 256:539–553CrossRef
5.
go back to reference Miglis MG (2017) Sleep and the autonomic nervous system. In: Sleep and neurologic disease, pp 227–241CrossRef Miglis MG (2017) Sleep and the autonomic nervous system. In: Sleep and neurologic disease, pp 227–241CrossRef
6.
go back to reference Fink AM, Bronas UG, Calik MW (2018) Autonomic regulation during sleep and wakefulness: a review with; implications for defning the pathophysiology of neurological disorders. Clin Auton Res 28:509–518CrossRef Fink AM, Bronas UG, Calik MW (2018) Autonomic regulation during sleep and wakefulness: a review with; implications for defning the pathophysiology of neurological disorders. Clin Auton Res 28:509–518CrossRef
7.
go back to reference Jain S (2011) Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord 17:77–83CrossRef Jain S (2011) Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord 17:77–83CrossRef
8.
go back to reference Shneyder N, Adler CH, Hentz JG, Shill H, Caviness JN, Sabbagh MN, Beach TG, Driver-Dunckley E (2013) Autonomic complaints in patients with restless legs syndrome. Sleep Med 14:1413–1416CrossRef Shneyder N, Adler CH, Hentz JG, Shill H, Caviness JN, Sabbagh MN, Beach TG, Driver-Dunckley E (2013) Autonomic complaints in patients with restless legs syndrome. Sleep Med 14:1413–1416CrossRef
9.
go back to reference Isak B, Uluc K, Salcini C, Agan K, Tanridag T, Us O (2011) A neurophysiological approach to the complex organisation of the spine: f-wave duration and the cutaneous silent period in restless legs syndrome. Clin Neurophysiol 122:383–390CrossRef Isak B, Uluc K, Salcini C, Agan K, Tanridag T, Us O (2011) A neurophysiological approach to the complex organisation of the spine: f-wave duration and the cutaneous silent period in restless legs syndrome. Clin Neurophysiol 122:383–390CrossRef
10.
go back to reference Izzi F, Placidi F, Romigi A, Lauretti B, Marfia GA, Mercuri NB, Marciani MG, Rocchi C (2014) Is autonomic nervous system involved in restless legs syndrome during wakefulness? Sleep Med 15:1392–1397CrossRef Izzi F, Placidi F, Romigi A, Lauretti B, Marfia GA, Mercuri NB, Marciani MG, Rocchi C (2014) Is autonomic nervous system involved in restless legs syndrome during wakefulness? Sleep Med 15:1392–1397CrossRef
11.
go back to reference Tyvaert L, Laureau E, Hurtevent JP, Hurtevent JF, Derambure P, Monaca C (2009) A-delta and C-fibres function in primary restless legs syndrome. Neurophysiol Clin 39:267–274CrossRef Tyvaert L, Laureau E, Hurtevent JP, Hurtevent JF, Derambure P, Monaca C (2009) A-delta and C-fibres function in primary restless legs syndrome. Neurophysiol Clin 39:267–274CrossRef
12.
go back to reference Shukla G, Goyal V, Srivastava A, Behari M (2012) Quantitative thermal sensory testing and sympathetic skin response in primary restless legs syndrome - a prospective study on 57 Indian patients. Ann Indian Acad Neurol 15:260–262CrossRef Shukla G, Goyal V, Srivastava A, Behari M (2012) Quantitative thermal sensory testing and sympathetic skin response in primary restless legs syndrome - a prospective study on 57 Indian patients. Ann Indian Acad Neurol 15:260–262CrossRef
13.
go back to reference Visser M, Marinus J, Stiggelbout A, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRef Visser M, Marinus J, Stiggelbout A, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRef
14.
go back to reference Yasar H, Senol MG, Tasdemir S et al (2016) Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT). Mov Disord 31(suppl 2):516-517 Yasar H, Senol MG, Tasdemir S et al (2016) Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT). Mov Disord 31(suppl 2):516-517
15.
go back to reference Walters AS et al (2003) Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4:121–132CrossRef Walters AS et al (2003) Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4:121–132CrossRef
16.
go back to reference Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC (2000) Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 55:1115–1121CrossRef Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC (2000) Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 55:1115–1121CrossRef
17.
go back to reference Iannaccone S, Zucconi M, Marchettini P, Ferini-Strambi L, Nemni R, Quattrini A, Palazzi S, Lacerenza M, Formaglio F, Smirne S (1995) Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 10:2–9CrossRef Iannaccone S, Zucconi M, Marchettini P, Ferini-Strambi L, Nemni R, Quattrini A, Palazzi S, Lacerenza M, Formaglio F, Smirne S (1995) Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 10:2–9CrossRef
18.
go back to reference Pavy-Le Traon A, Amarenco G, Duerr S et al (2011) The movement disorders task force review of dysautonomia rating scales in Parkinson’s disease with regard to symptoms of orthostatic hypotension. Mov Disord 26:1985–1992CrossRef Pavy-Le Traon A, Amarenco G, Duerr S et al (2011) The movement disorders task force review of dysautonomia rating scales in Parkinson’s disease with regard to symptoms of orthostatic hypotension. Mov Disord 26:1985–1992CrossRef
19.
go back to reference Damon-Perrière N, Foubert-Samier A, De Cock VC et al (2012) Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord 18:612–615CrossRef Damon-Perrière N, Foubert-Samier A, De Cock VC et al (2012) Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord 18:612–615CrossRef
20.
go back to reference Papapetropoulos S, Argyriou AA, Chroni E (2006) No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson’s disease. Mov Disord 21:430–431CrossRef Papapetropoulos S, Argyriou AA, Chroni E (2006) No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson’s disease. Mov Disord 21:430–431CrossRef
21.
go back to reference Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A, Arnulf I, Birgit H, Manni R, Miyamoto T, Fantini ML, Puligheddu M, Jennum P, Sonka K, Santamaria J, Zucconi M, Rancoita PMV, Leu-Semenescu S, Frauscher B, Terzaghi M, Miyamoto M, Unger M, Stiasny-Kolster K, Desautels A, Wolfson C, Pelletier A, Montplaisir J (2014) Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J Neurol 261:1112–1118CrossRef Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A, Arnulf I, Birgit H, Manni R, Miyamoto T, Fantini ML, Puligheddu M, Jennum P, Sonka K, Santamaria J, Zucconi M, Rancoita PMV, Leu-Semenescu S, Frauscher B, Terzaghi M, Miyamoto M, Unger M, Stiasny-Kolster K, Desautels A, Wolfson C, Pelletier A, Montplaisir J (2014) Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J Neurol 261:1112–1118CrossRef
Metadata
Title
Autonomic dysfunction in restless legs syndrome
Authors
Yuksel Erdal
Ozlem Akdogan
Mecbure Nalbantoglu
Gokce Kavasoglu
Ufuk Emre
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 3/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-019-01939-8

Other articles of this Issue 3/2020

Sleep and Breathing 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine